(Q48125410)

8 February 2018

title

Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. (English)

1 reference

8 February 2018

0 references

1 reference

Jayanta Samanta

1

1 reference

8 February 2018

Radha K Dhiman

2

1 reference

8 February 2018

Amit Khatri

3

1 reference

8 February 2018

Kiran K Thumburu

4

1 reference

8 February 2018

Sandeep Grover

5

1 reference

8 February 2018

Ajay Duseja

6

1 reference

8 February 2018

Yogesh Chawla

7

1 reference

8 February 2018

publication date

15 March 2013

1 reference

8 February 2018

published in

Metabolic Brain Disease

1 reference

8 February 2018

volume

28

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

249-259

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s11011-013-9393-3

exact match

0 references

cites work

Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

High prevalence of sleep disturbance in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Sleep disorders in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Progressive reduction of sleep time and quality in rats with hepatic encephalopathy caused by portacaval shunts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Factors associated with poor health-related quality of life of patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Relaxation therapy for insomnia: nighttime and day time effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

On the origin and the consequences of circadian abnormalities in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Two-sided confidence intervals for the single proportion: comparison of seven methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Disruption of the diurnal rhythm of plasma melatonin in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Systemic inflammation and ammonia in hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9393-3

Quality of life in people with insomnia.

21 January 2018

1 reference

12 December 2020

Subclinical hepatic encephalopathy impairs daily functioning

1 reference

12 December 2020

Psychological status and depression in patients with liver cirrhosis.

1 reference

12 December 2020

Portacaval anastomosis disrupts circadian locomotor activity and pineal melatonin rhythms in rats.

1 reference

12 December 2020

10.1007/S11011-013-9393-3

Identifiers

DOI

1 reference

8 February 2018

release_qyavnvtvazbddorkxzadne3lve

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qyavnvtvazbddorkxzadne3lve

24 November 2022

mapped directly with Wikidata item

PubMed ID

23494591

1 reference

8 February 2018